▼ SELL
$ Value
$801K
Shares
18,200
Price
$44
Filed
Aug 28
Insider
Name
Stanton Marshall S.
Title
SVP, Clinical & MD Affair
CIK
0001849615
Roles
Officer
Transaction Details
Transaction Date
2025-08-27
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
64,200
Footnotes
Reflects weighted average price. Range of prices were between $43.84 to $44.26. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. | Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was November 8, 2023.
Filing Info
Stanton Marshall S.'s History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-03 | AORT | ▼ | $81K |
| 2026-03-02 | AORT | ▼ | $58K |
| 2026-03-02 | AORT | A | $0 |
| 2026-02-24 | AORT | ▼ | $45K |
| 2026-02-23 | AORT | ▼ | $91K |
| 2025-11-21 | AORT | M | $374K |
| 2025-11-21 | AORT | ▼ | $655K |
| 2025-11-21 | AORT | ▼ | $259K |
| 2025-11-21 | AORT | M | $299K |
| 2025-11-21 | AORT | ▼ | $840K |
Other Insiders at AORT (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Horton Amy
VP, Chief Accounting Officer
|
— | $153K | 2026-03-03 |
|
Mackin James P
President & CEO
|
— | $2.5M | 2026-03-03 |
|
Berry Lance A
EVP, COO, CFO & Treasurer
|
— | $783K | 2026-03-03 |
|
Holloway Jean F
SVP, General Counsel
|
— | $744K | 2026-03-04 |
|
Davis John E
Chief Commercial Officer
|
— | $494K | 2026-03-03 |
|
Stanton Marshall S.
SVP, Clinical & MD Affair
|
— | $275K | 2026-03-03 |